Amarin Corporation PLC AMRN:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:40 PM EDT
1.39quote price arrow down-0.02 (-1.42%)
Volume
2,922
Close
1.41quote price arrow down-0.04 (-2.76%)
Volume
1,617,030
52 week range
1.11 - 5.97
Loading...
  • Open1.41
  • Day High1.48
  • Day Low1.39
  • Prev Close1.45
  • 52 Week High5.97
  • 52 Week High Date08/23/21
  • 52 Week Low1.11
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap568.53M
  • Shares Out403.21M
  • 10 Day Average Volume3.35M
  • Dividend-
  • Dividend Yield-
  • Beta1.84
  • YTD % Change-58.16

KEY STATS

  • Open1.41
  • Day High1.48
  • Day Low1.39
  • Prev Close1.45
  • 52 Week High5.97
  • 52 Week High Date08/23/21
  • 52 Week Low1.11
  • 52 Week Low Date05/12/22
  • Market Cap568.53M
  • Shares Out403.21M
  • 10 Day Average Volume3.35M
  • Dividend-
  • Dividend Yield-
  • Beta1.84
  • YTD % Change-58.16

RATIOS/PROFITABILITY

  • EPS (TTM)-0.25
  • P/E (TTM)-5.56
  • Fwd P/E (NTM)-6.62
  • EBITDA (TTM)-46.027M
  • ROE (TTM)-16.32%
  • Revenue (TTM)475.60M
  • Gross Margin (TTM)75.00%
  • Net Margin (TTM)-21.02%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/04/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Amarin Corporation PLC

There is no recent news for this security.

Profile

MORE
Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics for cardiovascular disease management. The Company operates through the development and commercialization of Vascepa segment. Its lead product, Vascepa (icosapent ethyl) capsule for use as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE...
Per Wold - Olsen
Non-Executive Independent Chairman of the Board
Karim Mikhail
President, Chief Executive Officer, Director
Thomas Reilly
Chief Financial Officer, Senior Vice President
Aaron Berg
Executive Vice President, President - US
Jason Marks
Executive Vice President, Chief Legal and Compliance Officer and Corporate Secretary
Address
Gemini House, Bartholomews Walk
Dublin
FK7 9JQ
Ireland

Top Peers

SYMBOLLASTCHG%CHG
EGRX
Eagle Pharmaceuticals Inc
36.86-6.23-14.46%
COLL
Collegium Pharmaceutical Inc
19.35-0.15-0.77%
VNDA
Vanda Pharmaceuticals Inc
10.27-0.25-2.38%
ANIP
ANI Pharmaceuticals Inc
34.00-0.87-2.50%
INVA
Innoviva Inc
14.37-0.42-2.84%